STAAR Surgical To Present At The 34th Annual Cowen Health Care Conference

Feb 24, 2014, 06:30 ET from STAAR Surgical Company

MONROVIA, Calif., Feb. 24, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will participate in the 34th Annual Cowen Health Care Conference at the Boston Marriott Copley Place Hotel on Monday, March 3 at 4:50 p.m. ET. 

Barry Caldwell, President and CEO, and Steve Brown, CFO will present a general overview of the business, the Company's recent financial results, and current operational developments. A live webcast, including accompanying slides, will be available from the Company's website,, under Investor Information. An archived replay of the presentation will be available for 90 days, also at

About STAAR Surgical STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." Over 400,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: STAAR has approximately 300 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at

Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material. 




EVC Group

EVC Group

Doug Sherk, 415-652-9100

Nicole Kruse

Leigh Salvo, 415-568-9348


SOURCE STAAR Surgical Company